4-(3-CARBAMOYL-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-4-YL)-3-METHOXYBENZOIC ACID, (S)-
UNII 4BTQ5P7WRM
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(3-carbamoyl-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-4-yl)-3-methoxybenzoic Acid, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4BTQ5P7WRM.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H23N3O5 RMXJACBAUKTQLR-MRXNPFEDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(3-carbamoyl-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-4-yl)-3-methoxybenzoic Acid, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.